Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism.
Affiliation
Department of Emergency Medicine, Cancer Emergency Room, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaIssue Date
2018-05-04
Metadata
Show full item recordAbstract
The EPIPHANY index was developed to classify cancer associated pulmonary embolism (PE) into different risk categories using decision tree modeling. In this study, we tried to externally validate this index in a distinct group of patients solely composed of incidental PE (IPE).Citation
Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. 2018, Support Care CancerJournal
Supportive Care in CancerDOI
10.1007/s00520-018-4235-9PubMed ID
29725804Type
ArticleLanguage
enISSN
1433-7339ae974a485f413a2113503eed53cd6c53
10.1007/s00520-018-4235-9